ACHT(SH:600207)2025-01-17 10:10Financial Performance Expectations - The company expects a net profit attributable to shareholders for 2024 to be between -420 million and -320 million CNY, a decrease of 300.71 million to 400.71 million CNY compared to the previous year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be between -482.4 million and -382.4 million CNY, a decrease of 320.72 million to 420.72 million CNY year-on-year[3]. - In 2023, the net profit attributable to shareholders was -19.287 million CNY, and the net profit after deducting non-recurring gains and losses was -61.677 million CNY[6]. - The company reported an earnings per share of -0.0177 CNY for the previous year[6]. Market Conditions and Challenges - The primary reasons for the expected loss include a significant decline in the price of photovoltaic glass products and a decrease in the gross profit margin of the company's photovoltaic glass business due to supply-demand mismatches[7]. - The company also faces increased competition in the borosilicate pharmaceutical glass market, leading to a substantial drop in product prices and gross profit margins[7]. - The company has made provisions for impairment on inventory and certain production facilities in response to current market conditions[7]. Forecast and Investment Advisory - There are no significant uncertainties expected to affect the accuracy of this earnings forecast[8]. - The forecast data is preliminary and subject to change pending the audited annual report for 2024[9]. - Investors are advised to be cautious regarding investment risks based on the preliminary nature of the forecast[9].